Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2171611 | Cytotherapy | 2012 | 7 Pages |
Abstract
The prevalence of poor mobilization was high, being associated with disease type, therapy with purine analogs and multiple chemotherapy regimens. The threshold of CD34+ cell count in PB identified poor mobilizers, in whom the administration of immediate or pre-emptive plerixafor could be useful to avoid a second mobilization.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Juan-Manuel Sancho, Mireia Morgades, Joan-Ramon Grifols, Jordi Juncà , Ramon Guardia, Susana Vives, Christelle Ferrà , Monsterrat Batlle, Anna Ester, David Gallardo, Fuensanta Millà , Evarist Feliu, Josep-Maria Ribera,